Our current understanding of genetic alterations in colorectal cancer, and implications for clinical use

Oncology Spectrums

Volumn 2, Issue 4, 2001, Pages 234-238

  Esteller, Manel ^a   Sanchez Cespedes, Montserrat ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; APC; BIOLOGICAL MARKER; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P14; PROTEIN P16; PROTEIN P53;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME MUTATION; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; EARLY DIAGNOSIS; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC DISORDER; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE K RAS; PEUTZ JEGHERS SYNDROME; PREDICTION; TUMOR SUPPRESSOR GENE;

EID: 0035722271     PISSN: 15328554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Colorectal cancer
2. Colorectal cancer
3. ras genes
4. Prevalence of ras gene mutations in human colorectal cancers
5. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
6. p53-dependent cell cycle control: Response to genotoxic stress
7. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms
8. Identification and characterization of the familial adenomatous polyposis coli gene
9. Activation of the beta-catenin-Tcf signaling in colon cancer by mutations in the beta-catenin or APC
10. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
11. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
12. Allelic loss on chromosome 18q and prognosis in colorectal cancer
13. Epigenetic lesions causing genetic lesions in human cancer. promoter hypermethylation of DNA repair genes
14. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
15. Hypermethylation-associated inactivation inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
16. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
17. Inactivation of the DNA repair gene 06-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
18. Inactivation of the DNA repair gene 06-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
19. A genetic model for colorectal tumorigenesis
20. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
21. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
22. Cowden's disease
23. Germline mutations of the PTEN gene in Cowden disease, as inherited breast and thyroid cancer syndrome
24. Juvenile polyposis and gastrointestinal carcinoma
25. A prospective study of family history and the risk of colorectal cancer
26. The International Collaborative Group on hereditary non-polyposis colorectal cancer
27. The Human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer
28. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
29. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
30. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
31. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
32. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence
33. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
34. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-flourouracil